Lotery, Andrew J. and Burdon, Michael A. (2018) Bevacizumab: a new way of doing business. Part 2. Eye, 33 (4), 519-520. (doi:10.1038/s41433-018-0281-2).
Record type:
Editorial
This record has no associated files available for download.
More information
Accepted/In Press date: 7 November 2018
e-pub ahead of print date: 27 November 2018
Identifiers
Local EPrints ID: 430663
URI: http://eprints.soton.ac.uk/id/eprint/430663
ISSN: 0950-222X
PURE UUID: 5c3669e1-30c8-45e8-b759-2dba1c09d36f
Catalogue record
Date deposited: 08 May 2019 16:30
Last modified: 16 Mar 2024 03:32
Export record
Altmetrics
Contributors
Author:
Michael A. Burdon
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.